Sign in
CBUS Stock Price, Chart, Stats & News
Cibus, Inc.
Save
Cibus, Inc. (CBUS) does not currently pay a dividend.
116.02M
Market cap
–
Current P/E
–
Forward P/E
CBUS chart
Fundamentals
Gross margin | 23.91% |
Operating margin | -1853.92% |
Pretax margin | -3632.10% |
Net margin | -3492.31% |
Effective tax rate | -0.02% |
ROA | -41.66% |
ROE | -236.85% |
D/E | 12.28x |
Interest coverage ratio | -1.91x |
CBUS valuation
P/E | – |
P/S | 23.50x |
P/B | 39.41x |
P/CF | -17.00x |
P/FCF | -1.67x |
P/OCF | -17.00x |
PEG | -0.56x |
EV multiple | 2.80x |
About
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023.
Similar securities
Based on sector and market capitalization
Report issue